+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transdermal Drug Delivery Systems Market Analysis, By Type (Patches And Semisolid Formulations) By Technology Type (Thermal, Iontophoresis, Electroporation, Ultrasound, Electric Current, Microporation) By Applications Type, By End Use, Forecasts To 2026

  • ID: 5351573
  • Report
  • November 2019
  • Region: Global
  • 150 pages
  • Reports and Data
Increasing prevalence of various chronic conditions including hypertension and growing adoption of transdermal drug delivery systems are key factors driving market revenue growth.

Market Size - USD 1,453.7 Million in 2020, Market Growth - CAGR of 6.6%, Market Trends - Increasing focus on research and development of advanced transdermal drug delivery systems and rising number of product launches.

The global transdermal drug delivery systems market size is expected to reach USD 2,429.1 Million in 2028, and register a CAGR of 6.6% during the forecast period. Shifting preference of healthcare professionals to deliver painless medications, and prominent advantage of these systems such as maintenance of constant serum level of the drug are some of the factors expected to drive growth of the global transdermal drug delivery systems market.

Transdermal drug delivery is a method of administering medications through the skin, in which the systemic circulation gradually absorbs medicines. Rapidly growing technological advancements in the field, and rising adoption of third-generation systems, growing global geriatric population, and increasing prevalence of various chronic diseases and infectious diseases, especially in developing countries are other major factors driving market growth.

Some Key Findings From the Report:
  • Among the product type segments, the equipment segment accounted for the largest revenue share of 54.6% in 2020.
  • North America market accounted for major revenue share in the global transdermal drug delivery systems market in 2020, and is expected to continue with dominance over the forecast period.
  • The Asia Pacific market size was USD 334.4 Million in 2020, due to increasing investments in development of advanced healthcare infrastructure and growing medical tourism sector in countries in the region.
  • Key players profiled in the report include Hisamitsu Pharmaceutical Co., Inc. (Japan), Mylan N.V. (US), UCB S.A. (Belgium), Novartis International AG (Switzerland), GlaxoSmithKline PLC (UK), Boehringer Ingelheim/ C.H. Boehringer Sohn AG & Ko. KG (Germany), Johnson & Johnson (US), Endo International PLC (Ireland), and Purdue Pharma L. P. (US). The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global transdermal drug delivery systems market is segmented on the basis of type, technology type, application, end use, and region:

Type Outlook
  • Patches
  • Semisolid Formulations
  • Others
Technology Type Outlook
  • Thermal
  • Iontophoresis
  • Electroporation
  • Ultrasound
  • Electric Current
  • Microporation
  • Mechanical Arrays
  • Radio Frequency
Application Outlook
  • Pain Management
  • Central Nervous System Disorders
  • Hormonal Applications
  • Cardiovascular Diseases
End Use Outlook
  • Hospital
  • Clinic
  • Others
Region Outlook
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa
Reasons to Buy the Report
  • A robust analysis and estimation of the Transdermal Drug Delivery Systems Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in the Transdermal Drug Delivery Systems Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Note: Product cover images may vary from those shown
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 2026

Chapter 3. Indicative Metrics
3.1. Rising prevalence of chronic disease
3.2. Technological advancements
3.3. Development in healthcare
3.4. Government rules and regulations

Chapter 4. Transdermal Drug Delivery System Segmentation & Impact Analysis
4.1. Transdermal Drug Delivery System Segmentation Analysis
4.2. Transdermal Drug Delivery System Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Transdermal Drug Delivery System Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. Increased adoption of advanced technology
4.4.1.2. Rise in geriatric population
4.4.2. Market restraint analysis
4.4.2.1. Lack of awareness
4.4.2.2. Associated side-effects
4.5. Key opportunities prioritized
4.6. Transdermal Drug Delivery System Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Transdermal Drug Delivery System PESTEL Analysis

Chapter 5. Transdermal Drug Delivery System Market By Type Insights & Trends
5.1. Transdermal Drug Delivery System Type dynamics & Market Share, 2018 & 2026
5.2. Patches
5.2.1. Market estimates and forecast, 2016 2026 (USD Million)
5.2.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
5.3. Semisolid formulations
5.3.1. Market estimates and forecast, 2016 2026 (USD Million)
5.3.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
5.4. Others
5.4.1. Market estimates and forecast, 2016 2026 (USD Million)
5.4.2. Market estimates and forecast, by region, 2016 2026 (USD Million)

Chapter 6. Transdermal Drug Delivery System Market By Technology Type Insights & Trends
6.1. Transdermal Drug Delivery System Technology Type dynamics & Market Share, 2018 & 2026
6.2. Thermal
6.2.1. Market estimates and forecast, 2016 2026 (USD Million)
6.2.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.3. Iontophoresis
6.3.1. Market estimates and forecast, 2016 2026 (USD Million)
6.3.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.4. Electroporation
6.4.1. Market estimates and forecast, 2016 2026 (USD Million)
6.4.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.5. Ultrasound
6.5.1. Market estimates and forecast, 2016 2026 (USD Million)
6.5.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.6. Electric Current
6.6.1. Market estimates and forecast, 2016 2026 (USD Million)
6.7. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.7.1. Market estimates and forecast, 2016 2026 (USD Million)
6.7.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.8. Microporation
6.8.1. Market estimates and forecast, 2016 2026 (USD Million)
6.8.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.9. Mechanical Arrays
6.9.1. Market estimates and forecast, 2016 2026 (USD Million)
6.9.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.10. Radio Frequency
6.10.1. Market estimates and forecast, 2016 2026 (USD Million)
6.10.2. Market estimates and forecast, by region, 2016 2026 (USD Million)

Chapter 7. Transdermal Drug Delivery System Market By Applications Type Insights & Trends
7.1. Transdermal Drug Delivery System Applications Type dynamics & Market Share, 2018 & 2026
7.2. Pain Management
7.2.1. Market estimates and forecast, 2016 2026 (USD Million)
7.2.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
7.3. Central Nervous System Disorders
7.3.1. Market estimates and forecast, 2016 2026 (USD Million)
7.3.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
7.4. Hormonal Applications
7.4.1. Market estimates and forecast, 2016 2026 (USD Million)
7.4.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
7.5. Cardiovascular Diseases
7.5.1. Market estimates and forecast, 2016 2026 (USD Million)
7.5.2. Market estimates and forecast, by region, 2016 2026 (USD Million)

Chapter 8. Transdermal Drug Delivery System Market By End Use Insights & Trends
8.1. Transdermal Drug Delivery System End Use dynamics & Market Share, 2018 & 2026
8.2. Clinic
8.2.1. Market estimates and forecast, 2016 2026 (USD Million)
8.2.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
8.3. Hospital
8.3.1. Market estimates and forecast, 2016 2026 (USD Million)
8.3.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
8.4. Others
8.4.1. Market estimates and forecast, 2016 2026 (USD Million)
8.4.2. Market estimates and forecast, by region, 2016 2026 (USD Million)

Chapter 9. Transdermal Drug Delivery System Market Regional Outlook
9.1. Transdermal Drug Delivery System Market share by region, 2018 & 2026
9.2. North America
9.2.1. North America Transdermal Drug Delivery System Market estimates and forecast, 2016 2026, (USD Million)
9.2.2. North America Transdermal Drug Delivery System Market estimates and forecast by Type, 2016 2026, (USD Million)
9.2.3. North America Transdermal Drug Delivery System Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.2.4. North America Transdermal Drug Delivery System Market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.2.5. North America Transdermal Drug Delivery System Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.2.6. U.S.
9.2.6.1. U.S. Transdermal Drug Delivery System Market estimates and forecast, 2016 2026, (USD Million)
9.2.6.2. U.S. Transdermal Drug Delivery System Market estimates and forecast by Type, 2016 2026, (USD Million)
9.2.6.3. U.S. Transdermal Drug Delivery System Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.2.6.4. U.S. Transdermal Drug Delivery System Market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.2.6.5. U.S. Transdermal Drug Delivery System Market estimates and forecast by End use, 2016 2026, (USD Million)
9.2.7. Canada
9.2.7.1. Canada Transdermal Drug Delivery System Market estimates and forecast, 2016 2026, (USD Million)
9.2.7.2. Canada Transdermal Drug Delivery System Market estimates and forecast by Type, 2016 2026, (USD Million)
9.2.7.3. Canada Transdermal Drug Delivery System Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.2.7.4. Canada Transdermal Drug Delivery System Market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.2.7.5. Canada Transdermal Drug Delivery System Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3. Europe
9.3.1. Europe Transdermal Drug Delivery System Market estimates and forecast, 2016 2026, (USD Million)
9.3.2. Europe Transdermal Drug Delivery System Market estimates and forecast by Type, 2016 2026, (USD Million)
9.3.3. Europe Transdermal Drug Delivery System Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.4. Europe Transdermal Drug Delivery System Market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.3.5. Europe Transdermal Drug Delivery System Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.6. Germany
9.3.6.1. Germany Transdermal Drug Delivery System Market estimates and forecast, 2016 2026, (USD Million)
9.3.6.2. Germany Transdermal Drug Delivery System Market estimates and forecast by Type, 2016 2026, (USD Million)
9.3.6.3. Germany Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.6.4. Germany Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.3.6.5. Germany Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.7. France
9.3.7.1. France Transdermal Drug Delivery System Market estimates and forecast, 2016 2026, (USD Million)
9.3.7.2. France Transdermal Drug Delivery System Market estimates and forecast by Type, 2016 2026, (USD Million)
9.3.7.3. France Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.7.4. France Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.3.7.5. France Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.8. U.K.
9.3.8.1. U.K Transdermal Drug Delivery System market estimates and forecast, 2016 2026, (USD Million)
9.3.8.2. U.K Transdermal Drug Delivery System market estimates and forecast by Type, 2016 2026, (USD Million)
9.3.8.3. U.K. Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.8.4. U.K. Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.3.8.5. U.K. Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.9. Spain
9.3.9.1. Spain Transdermal Drug Delivery System market estimates and forecast, 2016 2026, (USD Million)
9.3.9.2. Spain Transdermal Drug Delivery System market estimates and forecast by Type, 2016 2026, (USD Million)
9.3.9.3. Spain. Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.9.4. Spain Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.3.9.5. Spain Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.10. Italy
9.3.10.1. Italy Transdermal Drug Delivery System Market estimates and forecast, 2016 2026, (USD Million)
9.3.10.2. Italy Transdermal Drug Delivery System Market estimates and forecast by Type, 2016 2026, (USD Million)
9.3.10.3. Italy Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.10.4. Italy Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.3.10.5. Italy Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.11. Rest of Europe
9.3.11.1. Rest of Europe Transdermal Drug Delivery System market estimates and forecast, 2016 2026, (USD Million)
9.3.11.2. Rest of Europe Transdermal Drug Delivery System market estimates and forecast by Type, 2016 2026, (USD Million)
9.3.11.3. Rest of Europe Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.11.4. Rest of Europe Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.3.11.5. Rest of Europe Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Transdermal Drug Delivery System market estimates and forecast, 2016 2026, (USD Million)
9.4.2. Asia Pacific Transdermal Drug Delivery System market estimates and forecast by Type, 2016 2026, (USD Million)
9.4.3. Asia Pacific Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.4. Asia Pacific Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.4.5. Asia Pacific Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4.6. China
9.4.6.1. China Transdermal Drug Delivery System market estimates and forecast, 2016 2026, (USD Million)
9.4.6.2. China Transdermal Drug Delivery System market estimates and forecast by Type, 2016 2026, (USD Million)
9.4.6.3. China Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.6.4. China Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.4.6.5. China Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4.7. Japan
9.4.7.1. Japan Transdermal Drug Delivery System market estimates and forecast, 2016 2026, (USD Million)
9.4.7.2. Japan Transdermal Drug Delivery System market estimates and forecast by Type, 2016 2026, (USD Million)
9.4.7.3. Japan Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.7.4. Japan Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.4.7.5. Japan Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4.8. India
9.4.8.1. India Transdermal Drug Delivery System market estimates and forecast, 2016 2026, (USD Million)
9.4.8.2. India Transdermal Drug Delivery System market estimates and forecast by Type, 2016 2026, (USD Million)
9.4.8.3. India Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.8.4. India Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.4.8.5. India Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4.9. Rest of Asia Pacific
9.4.9.1. Rest of Asia Pacific Transdermal Drug Delivery System market estimates and forecast, 2016 2026, (USD Million)
9.4.9.2. Rest of Asia Pacific Transdermal Drug Delivery System market estimates and forecast by Type, 2016 2026, (USD Million)
9.4.9.3. Rest of Asia Pacific Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.9.4. Rest of Asia Pacific Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.4.9.5. Rest of Asia Pacific Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.5. Middle East & Africa
9.5.1. Middle East and Africa Transdermal Drug Delivery System market estimates and forecast, 2016 2026, (USD Million)
9.5.2. Middle East and Africa Transdermal Drug Delivery System market estimates and forecast by Type, 2016 2026, (USD Million)
9.5.3. Middle East and Africa Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.5.4. Middle East and Africa Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.5.5. Middle East and Africa Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.6. Latin America
9.6.1. Latin America Transdermal Drug Delivery System market estimates and forecast, 2016 2026, (USD Million)
9.6.2. Latin America Transdermal Drug Delivery System market estimates and forecast by Type, 2016 2026, (USD Million)
9.6.3. Latin America Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.6.4. Latin America Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.6.5. Latin America Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)
9.6.6. Brazil
9.6.6.1. Brazil Transdermal Drug Delivery System market estimates and forecast, 2016 2026, (USD Million)
9.6.6.2. Brazil Transdermal Drug Delivery System market estimates and forecast by Type, 2016 2026, (USD Million)
9.6.6.3. Brazil Transdermal Drug Delivery System market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.6.6.4. Brazil Transdermal Drug Delivery System market estimates and forecast by Applications Type, 2016 2026, (USD Million)
9.6.6.5. Brazil Transdermal Drug Delivery System market estimates and forecast by End Use, 2016 2026, (USD Million)

Chapter 10. Competitive Landscape
10.1. Market Revenue Share by Manufacturers
10.2. Manufacturing Cost Breakdown Analysis
10.3. Mergers & Acquisitions
10.4. Strategy Benchmarking
10.5. Vendor Landscape

Chapter 11. Company Profiles
11.1. Hisamitsu Pharmaceutical
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Length Benchmarking
11.1.4. Strategic Initiatives
11.2. Mylan
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Length Benchmarking
11.2.4. Strategic Initiatives
11.3. UCB
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Length Benchmarking
11.3.4. Strategic Initiatives
11.4. Novartis
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Length Benchmarking
11.4.4. Strategic Initiatives
11.5. GlaxoSmithKline
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Length Benchmarking
11.5.4. Strategic Initiatives
11.6. Boehringer Ingelheim
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Length Benchmarking
11.6.4. Strategic Initiatives
11.7. Johnson & Johnson
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Length Benchmarking
11.7.4. Strategic Initiatives
11.8. Endo International
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Length Benchmarking
11.8.4. Strategic Initiatives
11.9. Purdue Pharma
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Length Benchmarking
11.9.4. Strategic Initiatives
Note: Product cover images may vary from those shown
Adroll
adroll